Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
The main objective of cardiovascular disease (CVD) prevention is to reduce morbidity and mortality. Despite recommendations on evidence-based pharmacological treatment and lifestyle changes, the control of CV risk factors such as hypertension or dyslipidaemia is not optimal. The use of a CV polypill...
Main Authors: | Lilian Grigorian-Shamagian, Klaus Edel, María Asunción Esteve-Pastor, Álvaro Aceña, Claudia Silva, Joana Delgado-Silva, Georges Ntaios, Eftychia Demerouti, Carlos Brotons |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.663361/full |
Similar Items
-
The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease – expert panel meeting report
by: Lilian Grigorian-Shamagian, et al.
Published: (2023-08-01) -
Does the Polypill Improve Patient Adherence Compared to Its Individual Formulations? A Systematic Review
by: Ana Baumgartner, et al.
Published: (2020-02-01) -
Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial
by: José M. Mostaza, et al.
Published: (2022-12-01) -
The Concept of the Polypill in the Prevention of Cardiovascular Disease
by: Brandon Wiley, et al.
Published: (2014-04-01) -
Uso de la polipíldora cardiovascular en la prevención secundaria de la enfermedad cerebrovascular
by: J. Masjuan, et al.
Published: (2021-01-01)